Clinical Trials
12 trialsNCT05296317 2026-02-19
EMEG-ECDD
Centre Georges Francois Leclerc
Phase NA Completed
NCT01850888 2025-12-18
MIBG for Refractory Neuroblastoma and Pheochromocytoma
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT01186224 2025-03-17
PHANTASTIC
University of Liverpool
Phase NA Completed
NCT01505569 2024-02-26
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT01526603 2024-02-26
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT02037256 2021-05-10
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT00741455 2020-11-23
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT02841722 2020-06-24
EMEG-E-01
Centre Georges Francois Leclerc
Phase NA Completed
NCT00096135 2017-03-21
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
Children's Oncology Group
Phase NA Completed
NCT00618813 2014-09-25
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
Children's Oncology Group
Phase NA Completed
NCT00231309 2014-08-22
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
Emory University
Phase NA Completed
NCT00066482 2013-10-17
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
Children's Oncology Group
Phase NA Completed